Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.
about
Role of microparticles in dengue virus infection and its impact on medical intervention strategiesThe biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progressionUse of SYTO 13, a fluorescent dye binding nucleic acids, for the detection of microparticles in in vitro systems.Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in ratsIncreased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension.Circulating microparticles: square the circle.Microvesicles at the crossroads between infection and cardiovascular diseasesMicroparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytesNanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation processMicroparticles: major transport vehicles for distinct microRNAs in circulation.Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1Impact of caspase-8 and PKA in regulating neutrophil-derived microparticle generation.N-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial CellsDevelopments in the synovial biology field 2006.Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesThe role of microparticles in inflammation and thrombosis.Heterogeneity in neutrophil microparticles reveals distinct proteome and functional propertiesThe role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation.Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.Microvesicles: potential markers and mediators of endothelial dysfunction.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityExploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein contentAre endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?Mechanisms for the formation of membranous nanostructures in cell-to-cell communication.Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease.Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblastsExploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles.Microparticles--messengers of biological information.The immune functions of phosphatidylserine in membranes of dying cells and microvesicles.Microsomal prostaglandin e synthase-1 in rheumatic diseases.Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity.Microvesicles in health and disease.Evolving role of biomarkers in acute cerebrovascular disease.Endothelial microparticles: missing link in endothelial dysfunction?Microvesiculation and disease.The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
P2860
Q26860307-3FA7C112-129F-4A2B-8525-954D762044EEQ28066054-DFB8225A-367E-4020-AF16-09217A0AFA77Q33914101-31B7D02A-A1C1-4F6F-AEED-2DC8F911C2F0Q34080036-52B2E722-490F-45D4-85BC-8E3A581DF930Q34138381-BAB185A2-A3FA-42C4-BE13-62A69D1A15A9Q34336698-9533BC8F-274A-4490-8E47-8578BCB3CBBCQ34680832-7D83B294-1CD3-4D87-B55A-3633AEF65C6CQ34961040-0A82E187-0B1C-4679-BB33-67880970B3BAQ35451359-4414EA29-798C-4514-88F0-DE0C49118CDEQ35576279-1BEFD807-B0E8-49AA-BB2F-6292A3106F5AQ35792749-07EA023A-686B-40AA-AC58-B21E17E2AC71Q35953495-86EC297F-FC9A-46CC-BBB2-97A54EECA17DQ36095677-A625331C-29A7-480E-8D0F-800A973C8BADQ36494128-4CAB0514-F28F-4E0B-8329-4C3E10E0D788Q36531479-DF4F18B4-709A-4D6A-9EDE-4992095867D5Q36794899-BAE2B227-C23D-4497-ADD2-CBE80C6CB240Q36868727-7E65EC1B-42F2-4EC7-AD47-EA07D407289AQ36884498-6958369F-7945-457B-AB35-06A202F63400Q37072869-6C0ACB4A-FA44-4B08-986A-2542E05BA62BQ37140804-77749E85-9960-4F59-A747-98D8B98B84D2Q37270759-A14A5960-79F3-4C09-ABF3-3C4C860DE2CFQ37273154-2E9ABF23-E745-4AFB-8F44-14254056C0AEQ37300823-C0C399D7-7C64-466F-B9DE-C241F30B1C12Q37454013-5608B638-2416-4643-9715-CAE9209A41D8Q37472712-2B55BD3A-4ACE-41B8-8C38-4E0B63F94BADQ37510353-B862D58C-6788-4F78-BA12-E0423DD3FE6EQ37530613-9828A503-49F0-4CB2-A432-5FF4AE35419CQ37544731-68712887-5AD7-413A-AEF1-2A9908005C0BQ37580734-CE9DA3DE-E1F5-4157-B82C-C311CC4C6973Q37618896-5E628356-FB86-4B2D-BBEC-00217300E460Q37643106-ACA6F7AA-785F-4EA2-B58B-C79041F4C64DQ37769584-1015FB4F-64FE-4F96-8581-5A271E9A4DE6Q37799738-23D05BCE-6549-45E8-A793-679F6E87437BQ37934565-E9F3D12E-C59C-4F0C-BEB1-89467C8D1C9BQ37950925-F4A69C1A-B8AD-4CDF-8C68-F2DCCB92AF54Q37981578-540593DC-D34B-41C3-8412-8443763A789DQ37997374-55A392D1-8739-4CBF-8CF5-80BD4E92AF6EQ38001993-83B25FEB-EDF7-457C-BB97-1AABF8110E81Q38077234-0919E83C-AC3E-44E4-8176-A5A70A67E2C7Q38106745-44857D1E-135B-444E-9303-8EFE9101ADDB
P2860
Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Microparticles as regulators o ...... alk in the rheumatic diseases.
@ast
Microparticles as regulators o ...... alk in the rheumatic diseases.
@en
Microparticles as regulators o ...... alk in the rheumatic diseases.
@nl
type
label
Microparticles as regulators o ...... alk in the rheumatic diseases.
@ast
Microparticles as regulators o ...... alk in the rheumatic diseases.
@en
Microparticles as regulators o ...... alk in the rheumatic diseases.
@nl
prefLabel
Microparticles as regulators o ...... alk in the rheumatic diseases.
@ast
Microparticles as regulators o ...... alk in the rheumatic diseases.
@en
Microparticles as regulators o ...... alk in the rheumatic diseases.
@nl
P2093
P356
P1476
Microparticles as regulators o ...... alk in the rheumatic diseases.
@en
P2093
David S Pisetsky
Joachim R Kalden
Jörg H W Distler
Lars C Huber
Oliver Distler
Steffen Gay
P304
P356
10.1002/ART.21350
P577
2005-11-01T00:00:00Z